Babesiosis: Difference between revisions
| Line 40: | Line 40: | ||
=Sources= | =Sources= | ||
<references/> | |||
*CDC http://www.cdc.gov/parasites/babesiosis/ | *CDC http://www.cdc.gov/parasites/babesiosis/ | ||
[[Category:ID]] | [[Category:ID]] | ||
Revision as of 15:04, 4 June 2015
Background
- Spread by the deer tick (Ixodes scapularis)
- People often unaware they are bitten
- Natural reservior is the white footed mouse
- Endemic in US, Europe, parts of Russia and China
- Babesia Microti is pathogen in US
Symptoms
- Fever, hemolytic anemia, chills, thrombocytopenia, DIC
- More severe disease in immunocompromized patients (HIV, Elderly, Asplenic)
Diagnosis
- Peripheral blood smear
- Shows intracellular parasites
- Maltese Cross sign
- May need large smear as parasitemia can be as low as 1%
- Can often be confused for malaria parasites
- Shows intracellular parasites
Differential Diagnosis
Tick Borne Illnesses
- Babesiosis
- Colorado tick fever
- Ehrlichiosis
- Heartland virus
- Lyme
- Murine typhus
- Rocky mountain spotted fever
- Southern tick-associated rash illness (STARI)
- Tick paralysis
- Tularemia
Management
- 2 drug regimen for 7-10 days
Option 1
- Atovaquone (750mg BID) and Azithromycin (500-1000mg on first day, 250-1000mg on subsequent days)
Option 2
- 600 mg PO q8h x 7-10 days
- Alt: 300-600mg IV q6h x 7-10 days
- First Dose: 300-600mg IV x 1
- Give with Quinine (650mg TID); use IV for severe infections
Pediatrics
- Clindamycin 20 mg/kg/day for children and 25 mg/kg/day for children for 7-10 days
Treatment Failure
- Atovaquone 750 mg q12 and azithromycin 500 mg on day 1 and 250 mg/day x 7 days[1]
See Also
Sources
- ↑ Krause PJ, Lepore T, Sikand VK, Gadbaw J Jr, Burke G, Telford SR 3rd, et al. Atovaquone and azithromycin for the treatment of babesiosis. N Engl J Med. Nov 16 2000;343(20):1454-8.
